During the Trading Day
10.10 -0.67 / -6.22%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.90 -0.20 / -1.98%
Volume: 113.4K

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 15.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a +48.51% increase from the last price of 10.10.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ZIOPHARM Oncology Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -38.89%
Growthannually -70.97%


Growthquarterly -41.18%
Growthannually -61.16%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account